The pre-operative levels and the postoperative increments of serum IL-6 (Δ2 h, Δ24 h and Δ48 h) showed no significant differences between different patients groups stratified by stage of tumor, histologic grade, and site of tumor (Table 8). This evidence concerns the gene IL6 and neoplasm.